| Balance Sheet Components |
Balance Sheet Components Inventories The components of inventory are summarized as follows (in thousands): | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | Raw materials | $ | 6,724 | | | $ | 4,300 | | | Work in progress | 1,735 | | | 584 | | | Finished goods | 7,865 | | | 9,642 | | | Total inventories | $ | 16,324 | | | $ | 14,526 | |
Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands): | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | Prepaid co-pay assistance program and rebates | $ | 9,958 | | | $ | 7,369 | | | Prepaid clinical trial costs | — | | | 3,244 | | | Prepaid insurance | 935 | | | 844 | | | Other prepaid expenses and current assets | 7,742 | | | 8,199 | | | Total prepaid expenses and other current assets | $ | 18,635 | | | $ | 19,656 | |
Accrued Liabilities Accrued liabilities consist of the following (in thousands): | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | Accrued sales deductions | $ | 63,560 | | | $ | 38,430 | | | Accrued compensation | 12,321 | | | 20,747 | | | Clinical trial accruals | 74 | | | — | | | Accrued expenses and other current liabilities | 11,899 | | | 7,616 | | | Total accrued liabilities | $ | 87,854 | | | $ | 66,793 | |
|